Literature DB >> 3071764

High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.

G A Nagel1, J H Beyer, W Holtkamp, D Emrich, M Kneba, H Luig, N Marschner, W Rauschning, C Unger, H E Wander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3071764     DOI： 10.1159/000216559

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  2 in total

1.  Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer. Results of a prospective multicenter trial.

Authors:  O F Lange; W Scheef; K D Haase; M Heckmann; R Leyendecker; G Urban; G Zegners
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.